About AlmataBio
AlmataBio is a company based in Georgiana (United States) founded in 2023, and was acquired by Avalo Therapeutics in March 2024. Biotechnology initiatives are pursued by AlmataBio in the United States. AlmataBio has raised $2.13 million across 1 funding round from investors including Avalo Therapeutics. Its chief executive, as recorded, is Patrick J Crutcher.
Company details
AlmataBio was founded in 2023 and is headquartered in Georgiana, United States. Leadership is provided by CEO Patrick J. Crutcher. The company operates within the biotechnology sector, though detailed services and operations are not publicly specified. Focus is maintained on potential innovations, with activities centered in the U.S. geographic area. Limited data is available on current projects or client engagements.
- Headquarters Georgiana, United States
- Stage Acquired
- Website almatabio.com
- Acquired by Avalo Therapeutics (Mar 2024)
- Total Equity Funding$2.13M (USD)
in 1 rounds
- Latest Funding Round$2.13M (USD), Seed
Nov 2023
- Investors
- Acquired byAvalo Therapeutics
(Mar 2024)
Funding Insights of AlmataBio
AlmataBio has successfully raised a total of $2.13M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.13 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.13M
- Total Rounds 1
- Last Round Seed — $2.13M
- First Round $2.13M
(Nov 2023)
All 1 funding rounds of AlmataBio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2023 | $2.13M | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in AlmataBio
AlmataBio has secured backing from 1 investor. Prominent investors backing the company include Avalo Therapeutics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Therapeutics for rare and immunological diseases are developed. | 2011 | avalotx.com | Wayne, United States |
Investor details for AlmataBio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AlmataBio
1 people are tracked at AlmataBio (1 in leadership).
| Name | Role | Group |
|---|---|---|
Patrick J Crutcher | CEO | Leadership |
Complete people profiles for AlmataBio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AlmataBio
3 dated milestones of AlmataBio across 1 years, from founding to its latest funding, stage changes and deals.
- Founded AlmataBio is founded.
- Funding First funding round of $2.1M.
- Exit Acquired by Avalo Therapeutics.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AlmataBio
AlmataBio was founded in 2023.
AlmataBio is headquartered in Georgiana, United States. It is registered at Georgiana, Alabama, United States.
Patrick J Crutcher is the CEO of AlmataBio, as recorded in our data.
AlmataBio is a funded company, having raised a total of $2.13M across 1 funding round to date. The company's 1st funding round was a Seed of $2.13M, raised on Nov 2023.
AlmataBio was founded in 2023 and is headquartered in Georgiana, United States. Leadership is provided by CEO Patrick J. Crutcher. The company operates within the biotechnology sector, though detailed services and operations are not publicly specified. Focus is maintained on potential innovations, with activities centered in the U.S. geographic area. Limited data is available on current projects or client engagements.
AlmataBio has 1 investor. Key investors include Avalo Therapeutics.
Yes. AlmataBio was acquired by Avalo Therapeutics in March 2024.